178 related articles for article (PubMed ID: 30848171)
1. Short Review: Genomic Alterations in Hürthle Cell Carcinoma.
Ganly I; McFadden DG
Thyroid; 2019 Apr; 29(4):471-479. PubMed ID: 30848171
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial DNA "common deletion" in post-fine needle aspiration infarcted oncocytic thyroid tumors.
Conti L; Vatrano S; Bertero L; Masu L; Pacchioni D; Daniele L; De Rosa G; Cassoni P; Volante M; Papotti M
Hum Pathol; 2017 Nov; 69():23-30. PubMed ID: 28962946
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors.
Jung CK; Kim Y; Jeon S; Jo K; Lee S; Bae JS
Hum Pathol; 2018 Nov; 81():9-17. PubMed ID: 29723601
[TBL] [Abstract][Full Text] [Related]
4. Hürthle cell tumors: using molecular techniques to define a novel classification system.
Belchetz G; Cheung CC; Freeman J; Rosen IB; Witterick IJ; Asa SL
Arch Otolaryngol Head Neck Surg; 2002 Mar; 128(3):237-40. PubMed ID: 11886336
[TBL] [Abstract][Full Text] [Related]
5. Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance.
Sobrinho-Simões M; Máximo V; Castro IV; Fonseca E; Soares P; Garcia-Rostan G; Oliveira MC
Int J Surg Pathol; 2005 Jan; 13(1):29-35. PubMed ID: 15735852
[TBL] [Abstract][Full Text] [Related]
6. RET rearrangements in archival oxyphilic thyroid tumors: new insights in tumorigenesis and classification of Hürthle cell carcinomas?
Musholt PB; Imkamp F; von Wasielewski R; Schmid KW; Musholt TJ
Surgery; 2003 Dec; 134(6):881-9; discussion 889. PubMed ID: 14668719
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.
Máximo V; Soares P; Lima J; Cameselle-Teijeiro J; Sobrinho-Simões M
Am J Pathol; 2002 May; 160(5):1857-65. PubMed ID: 12000737
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays.
Hoos A; Stojadinovic A; Singh B; Dudas ME; Leung DH; Shaha AR; Shah JP; Brennan MF; Cordon-Cardo C; Ghossein R
Am J Pathol; 2002 Jan; 160(1):175-83. PubMed ID: 11786411
[TBL] [Abstract][Full Text] [Related]
9. PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.
Nikiforova MN; Biddinger PW; Caudill CM; Kroll TG; Nikiforov YE
Am J Surg Pathol; 2002 Aug; 26(8):1016-23. PubMed ID: 12170088
[TBL] [Abstract][Full Text] [Related]
10. Genetics, Diagnosis, and Management of Hürthle Cell Thyroid Neoplasms.
McFadden DG; Sadow PM
Front Endocrinol (Lausanne); 2021; 12():696386. PubMed ID: 34177816
[TBL] [Abstract][Full Text] [Related]
11. Frequent chromosomal DNA unbalance in thyroid oncocytic (Hürthle cell) neoplasms detected by comparative genomic hybridization.
Tallini G; Hsueh A; Liu S; Garcia-Rostan G; Speicher MR; Ward DC
Lab Invest; 1999 May; 79(5):547-55. PubMed ID: 10334566
[TBL] [Abstract][Full Text] [Related]
12. Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy.
Ganly I; Ricarte Filho J; Eng S; Ghossein R; Morris LG; Liang Y; Socci N; Kannan K; Mo Q; Fagin JA; Chan TA
J Clin Endocrinol Metab; 2013 May; 98(5):E962-72. PubMed ID: 23543667
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm.
Covach A; Patel S; Hardin H; Lloyd RV
Endocr Pathol; 2017 Sep; 28(3):207-212. PubMed ID: 28660408
[TBL] [Abstract][Full Text] [Related]
14. Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance.
Máximo V; Sobrinho-Simões M
Virchows Arch; 2000 Aug; 437(2):107-15. PubMed ID: 10993269
[TBL] [Abstract][Full Text] [Related]
15. Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.
Máximo V; Preto A; Crespo A; Rocha AS; Machado JC; Soares P; Sobrinho-Simões M
BMC Cancer; 2004 Mar; 4():12. PubMed ID: 15043758
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Hurthle cell neoplasms of the thyroid by interphase fluorescence in situ hybridization.
Erickson LA; Jalal SM; Goellner JR; Law ME; Harwood A; Jin L; Roche PC; Lloyd RV
Am J Surg Pathol; 2001 Jul; 25(7):911-7. PubMed ID: 11420462
[TBL] [Abstract][Full Text] [Related]
17. Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma: A Review and Multidisciplinary 2023 Update.
Bischoff LA; Ganly I; Fugazzola L; Buczek E; Faquin WC; Haugen BR; McIver B; McMullen CP; Newbold K; Rocke DJ; Russell MD; Ryder M; Sadow PM; Sherman E; Shindo M; Shonka DC; Singer MC; Stack BC; Wirth LJ; Wong RJ; Randolph GW
JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):265-272. PubMed ID: 38206595
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal aberrations by comparative genomic hybridization in hürthle cell thyroid carcinomas are associated with tumor recurrence.
Wada N; Duh QY; Miura D; Brunaud L; Wong MG; Clark OH
J Clin Endocrinol Metab; 2002 Oct; 87(10):4595-601. PubMed ID: 12364440
[TBL] [Abstract][Full Text] [Related]
19. EIF1AX Mutation in a Patient with Hürthle Cell Carcinoma.
Topf MC; Wang ZX; Furlong K; Miller JL; Tuluc M; Pribitkin EA
Endocr Pathol; 2018 Mar; 29(1):27-29. PubMed ID: 28965201
[TBL] [Abstract][Full Text] [Related]
20. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
